Gilead Sciences Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Gilead Sciences Inc.

Gilead Sciences Inc. | Ownership

Companies that own Gilead Sciences Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

94,113,215

7.26%

1,124,467

0.23%

06/30/2018

BlackRock Fund Advisors

67,003,535

5.17%

-3,029,030

0.25%

06/30/2018

Capital Research & Management Co. (Global Investors)

57,036,667

4.4%

14,093,328

0.79%

06/30/2018

SSgA Funds Management, Inc.

54,437,317

4.2%

523,975

0.31%

06/30/2018

Parnassus Investments

19,526,902

1.51%

-183,958

5.5%

06/30/2018

Fidelity Management & Research Co.

18,980,626

1.46%

-4,208,813

0.14%

06/30/2018

Northern Trust Investments, Inc.

16,912,636

1.31%

414,690

0.28%

06/30/2018

T. Rowe Price Associates, Inc.

16,266,811

1.25%

-1,152,498

0.17%

06/30/2018

Dodge & Cox

16,259,811

1.25%

814,350

0.65%

06/30/2018

Geode Capital Management LLC

15,934,560

1.23%

-1,093,008

0.31%

06/30/2018

About Gilead Sciences

View Profile

Address	333 Lakeside Drive Foster City California 94404 United States
Employees	-
Website	http://www.gilead.com
Updated	07/08/2019
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands.